Loading clinical trials...
Loading clinical trials...
Proactive Therapeutic Drug Monitoring Versus Routine Care With the Novel Biologics in Psoriasis : a Pragmatic, Multicentric, Randomised, Controlled Study
Conditions
Interventions
Proactive TDM-based dosing of secukinumab
Proactive TDM-based dosing of ixekizumab
+1 more
Locations
15
Belgium
AZ Sint-Jan
Bruges, Belgium
CHU Saint-Pierre
Brussels, Belgium
UCL Saint-Luc
Brussels, Belgium
ULB Erasme
Brussels, Belgium
UZ Brussel
Brussels, Belgium
Grand Hôpital de Charleroi
Charleroi, Belgium
Start Date
December 20, 2024
Primary Completion Date
March 1, 2028
Completion Date
March 1, 2028
Last Updated
March 4, 2026
NCT04080635
NCT04340076
NCT03507946
NCT06191042
NCT05215561
NCT04099979
Lead Sponsor
University Hospital, Ghent
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions